ANT2 isoform required for cancer cell glycolysis - INRAE - Institut national de recherche pour l’agriculture, l’alimentation et l’environnement Access content directly
Journal Articles Journal of Bioenergetics and Biomembranes Year : 2005

ANT2 isoform required for cancer cell glycolysis

Abstract

The three adenine nucleotide translocator (ANT1 to ANT3) isoforms, differentially expressed in human cells, play a crucial role in cell bioenergetics by catalyzing ADP and ATP exchange across the mitochondrial inner membrane. In contrast to differentiated tissue cells, transformed cells, and their rho(0) derivatives, i.e. cells deprived of mitochondrial DNA, sustain a high rate of glycolysis. We compared the expression pattern of ANT isoforms in several transformed human cell lines at different stages of the cell cycle. The level of ANT2 expression and glycolytic ATP production in these cell lines were in keeping with their metabolic background and their state of differentiation. The sensitivity of the mitochondrial inner membrane potential (Delta psi) to several inhibitors of glycolysis and oxidative phosphorylation confirmed this relationship. We propose a new model for ATP uptake in cancer cells implicating the ANT2 isoform, in conjunction with hexokinase II and the beta subunit of mitochondrial ATP synthase, in the Delta psi maintenance and in the aggressiveness of cancer cells.

Dates and versions

hal-02679782 , version 1 (31-05-2020)

Identifiers

Cite

Arnaud Chevrollier, Dominique Loiseau, Béatrice Chabi, Gilles Renier, Olivier Douay, et al.. ANT2 isoform required for cancer cell glycolysis. Journal of Bioenergetics and Biomembranes, 2005, 37 (5), pp.307-316. ⟨10.1007/s10863-005-8642-5⟩. ⟨hal-02679782⟩
18 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More